N漢邦
688755
N澤潤新能
301636
森萱醫葯
830946
4
格力博
301260
5
拓新藥業
301089
(Q3)2025/03/31 | (FY)2024/12/31 | (Q9)2024/09/30 | (Q6)2024/06/30 | (Q3)2024/03/31 | (FY)2023/12/31 | (Q9)2023/09/30 | (Q6)2023/06/30 | (Q3)2023/03/31 | (FY)2022/12/31 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | -9.28%1.23億 | 18.98%6.88億 | 12.74%4.76億 | 0.72%3.04億 | 2.48%1.36億 | 10.01%5.78億 | 5.42%4.23億 | -3.85%3.02億 | -21.20%1.32億 | -40.72%5.26億 |
營業收入 | -9.28%1.23億 | 18.98%6.88億 | 12.74%4.76億 | 0.72%3.04億 | 2.48%1.36億 | 10.01%5.78億 | 5.42%4.23億 | -3.85%3.02億 | -21.20%1.32億 | -40.72%5.26億 |
營業總成本 | -4.54%1.41億 | 15.67%7.58億 | 13.50%5.36億 | 6.25%3.43億 | 1.69%1.48億 | 21.60%6.55億 | 24.43%4.72億 | 20.89%3.23億 | 3.98%1.46億 | -15.05%5.39億 |
營業成本 | -12.42%8,718.96萬 | 15.35%5.1億 | 10.88%3.57億 | -0.79%2.28億 | -3.00%9,955.68萬 | 16.73%4.42億 | 17.85%3.22億 | 13.17%2.3億 | -2.39%1.03億 | -24.80%3.79億 |
營業稅金及附加 | 103.20%65.2萬 | -8.85%158.41萬 | -42.46%87.31萬 | -53.66%55.5萬 | -26.76%32.09萬 | 74.32%173.78萬 | 89.62%151.73萬 | 68.69%119.76萬 | -13.54%43.81萬 | -78.95%99.69萬 |
銷售費用 | 71.03%607.78萬 | 38.26%2,336.32萬 | 26.30%1,554.38萬 | 27.21%1,018.15萬 | 0.59%355.37萬 | 25.09%1,689.77萬 | 36.84%1,230.68萬 | 51.82%800.36萬 | 28.69%353.29萬 | 12.75%1,350.88萬 |
管理費用 | 27.23%1,200.88萬 | 30.10%4,789.53萬 | 34.77%3,447.32萬 | 27.74%2,128.01萬 | 24.12%943.89萬 | 11.37%3,681.43萬 | 8.61%2,558萬 | 12.53%1,665.84萬 | 6.04%760.47萬 | 13.73%3,305.6萬 |
財務費用 | 54.19%-44.45萬 | 31.80%-105.9萬 | 13.36%-124.21萬 | 15.44%-112.53萬 | -9.89%-97.04萬 | 41.32%-155.29萬 | 33.28%-143.36萬 | -234.71%-133.08萬 | -344.91%-88.3萬 | -48.23%-264.63萬 |
-利息費用 | -15.93%15.56萬 | -31.78%97.29萬 | -49.83%56.18萬 | -54.16%38.75萬 | -60.54%18.5萬 | 30.66%142.61萬 | 30.98%111.97萬 | 42.85%84.54萬 | 48.57%46.9萬 | 105.90%109.15萬 |
-利息收入 | 47.88%-60.7萬 | 34.71%-211.14萬 | 32.14%-187.76萬 | 30.37%-153.82萬 | 15.21%-116.46萬 | 13.05%-323.37萬 | 7.10%-276.7萬 | -121.93%-220.92萬 | -163.71%-137.35萬 | -58.35%-371.92萬 |
研發費用 | -0.84%3,587.58萬 | 10.62%1.76億 | 15.16%1.29億 | 22.64%8,478.07萬 | 12.05%3,617.86萬 | 38.21%1.59億 | 49.67%1.12億 | 56.65%6,913.09萬 | 30.91%3,228.93萬 | 32.85%1.15億 |
信用減值損失 | 1,383.16%45.31萬 | -199.60%-35.77萬 | -44.74%-9.65萬 | 38.57%-14.04萬 | 123.38%3.05萬 | 0.84%-11.94萬 | -177.80%-6.67萬 | 21.90%-22.86萬 | 56.56%-13.07萬 | -110.09%-12.04萬 |
資產減值損失 | 38.44%-287.49萬 | 2.14%-1,053.37萬 | -167.21%-842.5萬 | -95.51%-467.59萬 | -180.52%-467萬 | -77.69%-1,076.37萬 | 52.14%-315.29萬 | -47.45%-239.16萬 | 23.07%-166.48萬 | -463.87%-605.77萬 |
非經營性淨收益 | ||||||||||
公允價值變動淨收益 | -55.54%154.95萬 | ---- | -23.05%596.88萬 | -49.17%328.02萬 | -42.21%348.53萬 | 208.55%715.72萬 | 361.96%775.63萬 | --645.37萬 | 10,210.59%603.1萬 | --231.97萬 |
投資淨收益 | -75.16%29.21萬 | 14.09%2,122.81萬 | -22.37%1,012.71萬 | -16.43%734.02萬 | -67.48%117.61萬 | 188.50%1,860.67萬 | 615.04%1,304.57萬 | 513.79%878.31萬 | 601.76%361.62萬 | 433.32%644.95萬 |
-其中:對聯營合營企業的投資收益 | ---- | ---- | ---- | ---- | ---- | 200.00%3.56萬 | ---48.56萬 | ---48.56萬 | ---26.71萬 | ---3.56萬 |
資產處置收益 | ---- | -86.26%22.77萬 | 539,083.45%22.81萬 | --22.74萬 | --0.01 | 22,831.60%165.67萬 | -99.41%42.3 | ---- | ---- | --7,224.64 |
其他收益 | -71.80%237.3萬 | -1.20%2,276.2萬 | 121.16%1,629.18萬 | 132.60%1,351.02萬 | 1,019.02%841.37萬 | 95.24%2,303.74萬 | -8.70%736.65萬 | 109.95%580.83萬 | -51.63%75.19萬 | 144.36%1,179.93萬 |
營業利潤 | -310.28%-1,653.72萬 | 2.43%-3,636.77萬 | -43.86%-3,511.79萬 | -526.09%-2,012.99萬 | 13.92%-403.07萬 | -3,011.68%-3,727.48萬 | -191.51%-2,441.17萬 | -106.62%-321.52萬 | -117.00%-468.27萬 | -99.50%128.02萬 |
加:營業外收入 | --6,626.38 | -100.00%0.27 | -40.15%1,032.26 | ---- | ---- | -52.44%1.34萬 | -16.54%1,724.78 | -20.38%1,644.51 | -20.38%1,644.51 | 872.30%2.82萬 |
減:營業外支出 | 33,247.44%8.7萬 | -77.65%9.58萬 | -46.51%9.22萬 | 57.14%5,593.8 | -90.48%260.89 | 793.71%42.85萬 | 259.78%17.24萬 | 72.12%3,559.77 | 57.88%2,740.57 | 35.80%4.79萬 |
利潤總額 | -312.25%-1,661.76萬 | 3.25%-3,646.34萬 | -43.23%-3,520.91萬 | -525.89%-2,013.55萬 | 13.94%-403.1萬 | -3,090.15%-3,768.98萬 | -192.31%-2,458.24萬 | -106.62%-321.71萬 | -117.00%-468.38萬 | -99.51%126.05萬 |
減:所得稅費用 | -248.77%-138.92萬 | 98.60%-2.06萬 | -131.78%-51.69萬 | -132.05%-66.27萬 | -165.28%-39.83萬 | 94.71%-146.7萬 | 149.29%162.66萬 | 233.43%206.76萬 | 158.39%61.02萬 | -239.11%-2,771.02萬 |
淨利潤 | -319.21%-1,522.85萬 | -0.61%-3,644.28萬 | -32.37%-3,469.22萬 | -268.47%-1,947.27萬 | 31.38%-363.27萬 | -225.03%-3,622.29萬 | -187.57%-2,620.91萬 | -110.54%-528.47萬 | -118.51%-529.4萬 | -87.80%2,897.06萬 |
持續經營淨利潤 | -319.21%-1,522.85萬 | -0.61%-3,644.28萬 | -32.37%-3,469.22萬 | -268.47%-1,947.27萬 | 31.38%-363.27萬 | -225.03%-3,622.29萬 | -187.57%-2,620.91萬 | -110.54%-528.47萬 | -118.51%-529.4萬 | -87.80%2,897.06萬 |
減:少數股東損益 | 46.50%-209.6萬 | -12.37%-1,927.19萬 | -20.55%-1,431.29萬 | -34.19%-886.34萬 | -31.37%-391.76萬 | -90.71%-1,715.02萬 | -125.28%-1,187.29萬 | -246.23%-660.52萬 | -415.15%-298.21萬 | -304.95%-899.28萬 |
歸屬于母公司所有者的淨利潤 | -4,708.31%-1,313.25萬 | 9.97%-1,717.09萬 | -42.15%-2,037.93萬 | -903.45%-1,060.94萬 | 112.33%28.5萬 | -150.24%-1,907.27萬 | -140.73%-1,433.62萬 | -97.46%132.05萬 | -107.92%-231.18萬 | -84.16%3,796.35萬 |
每股收益 | ||||||||||
基本每股收益 | -4,734.15%-0.19 | 10.71%-0.25 | -42.86%-0.3 | -850.00%-0.15 | 112.24%0.0041 | -145.90%-0.28 | -135.59%-0.21 | -97.89%0.02 | -105.98%-0.0335 | -86.83%0.61 |
稀釋每股收益 | -4,490.24%-0.18 | 11.11%-0.24 | -42.86%-0.3 | -850.00%-0.15 | 112.24%0.0041 | -144.26%-0.27 | -135.59%-0.21 | -97.89%0.02 | -105.98%-0.0335 | -86.83%0.61 |
其他綜合收益 | ||||||||||
綜合收益總額 | -319.21%-1,522.85萬 | -0.61%-3,644.28萬 | -32.37%-3,469.22萬 | -268.47%-1,947.27萬 | 31.38%-363.27萬 | -225.03%-3,622.29萬 | -187.57%-2,620.91萬 | -110.54%-528.47萬 | -118.51%-529.4萬 | -87.80%2,897.06萬 |
歸屬于母公司所有者的綜合收益總額 | -4,708.31%-1,313.25萬 | 9.97%-1,717.09萬 | -42.15%-2,037.93萬 | -903.45%-1,060.94萬 | 112.33%28.5萬 | -150.24%-1,907.27萬 | -140.73%-1,433.62萬 | -97.46%132.05萬 | -107.92%-231.18萬 | -84.16%3,796.35萬 |
歸屬於少數股東的綜合收益總額 | 46.50%-209.6萬 | -12.37%-1,927.19萬 | -20.55%-1,431.29萬 | -34.19%-886.34萬 | -31.37%-391.76萬 | -90.71%-1,715.02萬 | -125.28%-1,187.29萬 | -246.23%-660.52萬 | -415.15%-298.21萬 | -304.95%-899.28萬 |
貨幣單位 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 | 人民幣 |
會計準則 | 中國會計準則(2007) | 中國會計準則(2007) | 中國會計準則(2007) | 中國會計準則(2007) | 中國會計準則(2007) | 中國會計準則(2007) | 中國會計準則(2007) | 中國會計準則(2007) | 中國會計準則(2007) | 中國會計準則(2007) |
審計意見 | -- | -- | -- | -- | -- | 無保留意見 | -- | -- | -- | -- |
會計師事務所 | -- | -- | -- | -- | -- | 大華會計師事務所(特殊普通合夥) | -- | -- | -- | 大華會計師事務所(特殊普通合夥) |
FY:Financial Year 年度報告,相當於上市公司向SEC披露的10-K文件。
Q:Quarter 季度報告,相當於上市公司向SEC披露的10-Q文件,其中Q1、Q2、Q3、Q4為單季報,跨度為3個月;Q6、Q9為累計季報,Q6為6個月,Q9為9個月。